Regulatory
How Japan classifies botanical dietary supplements through PMDA and the Foods with Function Claims (FFC) system, and what this means for blushwood berry EBC-46 products.
Consumer Reports / Supplement
Long-term blushwood berry tincture users describe how they dilute the extract, the practical reasons behind it, and what dilution does and does not change about the supplement.
Botany
The seasonal timing of flowering, fruiting and seed maturation in Fontainea picrosperma, and how phenological patterns shape blushwood berry availability and seed chemistry.
Human Trials
How patient-reported outcome instruments are being integrated alongside RECIST and adverse-event reporting in tigilanol tiglate clinical trials, and why they matter for interpreting human data.
Mechanism of Action
How tigilanol tiglate's downstream signalling converges on mitochondrial outer membrane permeabilization, releasing cytochrome c and engaging the intrinsic apoptotic pathway in tumour cells.
Regulatory
How New Zealand classifies blushwood berry supplements under Medsafe and the Dietary Supplements Regulations, plus the pending Therapeutic Products Bill that will reshape the category.
Consumer Reports
How to store a blushwood berry tincture so that it actually matches the label at the end of its shelf life — covering temperature, light exposure and dispensing practice.
Botany
A look at the ripening biochemistry of blushwood berry fruit, the seed-coat changes that accompany dispersal, and what these processes mean for harvest timing.
Human Trials
Published Phase 2 human trial data for intratumoural tigilanol tiglate shows a distinctive safety signature: predominantly local, transient, and rarely systemic.
Mechanism of Action
Tigilanol tiglate, the active compound EBC-46, activates multiple PKC isoforms but does so with measurable selectivity. Here is what the kinase data shows.
Regulatory
How Health Canada's Natural Health Products Regulations classify blushwood berry extract supplements, the NPN licensing pathway, and what buyers should know.
Consumer Reports
Sublingual administration is a common choice for tincture-format supplements. Long-term EBC-46 tincture users report a range of hold-time practices — here is what those reports look like, and what the underlying physiology suggests.